Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0001104659-24-084997
Filing Date
2024-08-02
Accepted
2024-08-01 17:57:58
Documents
19

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 3906395
2 GRAPHIC lg_camp4-4c.jpg GRAPHIC 22380
3 GRAPHIC ph_identify-4c.jpg GRAPHIC 113569
4 GRAPHIC fc_ourpipeline-4c.jpg GRAPHIC 61093
5 GRAPHIC ph_geneexpression-4c.jpg GRAPHIC 80049
6 GRAPHIC bc_functionaldisorder-4c.jpg GRAPHIC 39549
7 GRAPHIC ph_sodiumacetate-4c.jpg GRAPHIC 59631
8 GRAPHIC pc_ucdpatient-4c.jpg GRAPHIC 51469
9 GRAPHIC bc_concentration-4c.jpg GRAPHIC 95842
10 GRAPHIC lc_ureaproduction-4clr.jpg GRAPHIC 56296
11 GRAPHIC lc_ammonialevel-4c.jpg GRAPHIC 97709
12 GRAPHIC lc_ammoniaureagen-4clr.jpg GRAPHIC 53186
13 GRAPHIC bc_ucdmrna-4clr.jpg GRAPHIC 52651
14 GRAPHIC lc_ureagenesisauc-4c.jpg GRAPHIC 47340
15 GRAPHIC fc_clinicaltrialdesign-4c.jpg GRAPHIC 57121
16 GRAPHIC bc_ldlrincrease-4c.jpg GRAPHIC 63081
17 GRAPHIC bc_ldlrreductions-4clr.jpg GRAPHIC 65452
18 GRAPHIC lc_syngap1brainsofmice-4clr.jpg GRAPHIC 59394
19 GRAPHIC lc_humanneurons-4c.jpg GRAPHIC 56220
  Complete submission text file 0001104659-24-084997.txt   5451510
Mailing Address ONE KENDALL SQUARE BUILDING 1400 WEST, 3RD FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 WEST, 3RD FLOOR CAMBRIDGE MA 02139 617-651-8867
Camp4 Therapeutics Corp (Filer) CIK: 0001736730 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: DRS/A | Act: 33 | File No.: 377-07276 | Film No.: 241168164
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)